MedPath

Effect of Aromatherapy on Neuropathic pain Arising from Diabet

Not Applicable
Conditions
diabetic neuropathy.
Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified
E09.40
Registration Number
IRCT20191106045352N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
75
Inclusion Criteria

Diabetic Patients
Ages 18 to 65 years
Willingness to participate in research
Obtain a score higher than or equal to 4 on the DN4 clinical acceptance questionnaire

Exclusion Criteria

Nonconformity the protocol
Not willing to continue cooperation
Existence of other diseases causing neuropathic pain (trauma, systemic diseases, autoimmune, etc.)
having any scars on the legs
catching up diabetic foot
sensitivity to essential oils
catching up coagulation disorders
pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The percentage of people with greater than or equal to 4 on the DN4 clinical acceptance questionnaire. Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: DN4 clinical acceptance questionnaire.;Pain Score in Pain Evaluation Criteria (VAS). Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: Pain Assessment Criterion (VAS).;Received score from Persian Quality of Life Questionnaire 36 Questions (Dr. Montazeri). Timepoint: Before the intervention, the second week, the fourth week. Method of measurement: Farsi Quality of Life Questionnaire 36 questions(Dr.Montazeri).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath